MB

MPM BioImpact Portfolio holdings

AUM $1.29B
1-Year Est. Return 141.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+141.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.29B
AUM Growth
+$421M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
49
New
Increased
Reduced
Closed

Top Buys

1
+$93.9M
2
+$88.1M
3
+$36.9M
4
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
5
CYTK icon
Cytokinetics
CYTK
+$31.8M

Top Sells

1
+$56.4M
2
+$32.7M
3
+$17.4M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$17.1M
5
VTYX
Ventyx Biosciences
VTYX
+$14.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORIC icon
26
Oric Pharmaceuticals
ORIC
$875M
$22.9M 1.77%
1,803,945
+5,228
QURE icon
27
uniQure
QURE
$1.8B
$22.4M 1.73%
1,369,231
-12,397
GLUE icon
28
Monte Rosa Therapeutics
GLUE
$1.67B
$19.4M 1.5%
1,176,928
+3,552
NTRA icon
29
Natera
NTRA
$32B
$18.6M 1.44%
93,074
-477
CLYM
30
Climb Bio
CLYM
$628M
$17.8M 1.37%
2,593,439
-78,041
ARQT icon
31
Arcutis Biotherapeutics
ARQT
$2.68B
$17.3M 1.34%
733,966
+202,766
URGN icon
32
UroGen Pharma
URGN
$1.37B
$17M 1.31%
943,803
+2,425
DRUG
33
Bright Minds Biosciences
DRUG
$864M
$15.5M 1.2%
212,175
-17,972
ZYME icon
34
Zymeworks
ZYME
$1.85B
$14.2M 1.09%
+565,249
BLTE
35
Belite Bio
BLTE
$5.78B
$14M 1.08%
88,045
+285
VRDN icon
36
Viridian Therapeutics
VRDN
$1.95B
$12.7M 0.98%
+649,873
ENGN icon
37
enGene Therapeutics
ENGN
$124M
$12.6M 0.97%
1,845,373
+4,475
ABVX
38
Abivax
ABVX
$10.6B
$11.9M 0.92%
107,268
+50,952
ALLO icon
39
Allogene Therapeutics
ALLO
$749M
$5.47M 0.42%
+2,242,933
ACRS icon
40
Aclaris Therapeutics
ACRS
$635M
$1.47M 0.11%
+391,918
HOWL icon
41
Werewolf Therapeutics
HOWL
$21.9M
$1.01M 0.08%
1,208,810
-184,747
MDGL icon
42
Madrigal Pharmaceuticals
MDGL
$11.5B
– –
-96,780
PTCT icon
43
PTC Therapeutics
PTCT
$6.13B
– –
-430,013
PTGX icon
44
Protagonist Therapeutics
PTGX
$6.4B
– –
-199,471
RCKT icon
45
Rocket Pharmaceuticals
RCKT
$335M
– –
-1,586,076
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.89B
– –
-70,000
VTYX
47
DELISTED
Ventyx Biosciences
VTYX
– –
-1,639,061
MAZE
48
Maze Therapeutics
MAZE
$1.46B
– –
-81,145
RAPT
49
DELISTED
RAPT Therapeutics
RAPT
– –
-397,906
1
2